TOKYO -- Japan's Takeda Pharmaceutical announced on Thursday that CEO Christophe Weber will step down in June 2026 and be succeeded by current U.S. business head Julie Kim, who would become the company's first female chief.
Pharmaceuticals
Japan's Takeda names 1st female CEO in leadership change
Current head Weber, who catapulted company to global ranks, to leave in 2026
Current CEO Christophe Weber will be replaced by Julie Kim, head of the U.S. division. (Source photos by Takeda)
Read Next
Latest on Pharmaceuticals
